Inventors generated NKp44 monocolonal antibodies by immunizing mice with a NKp44-human crystallizable fragment (Fc) fusion protein. The antibodies have been used to study innate and adaptive immune responses.

Publication: Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44